Enteral Nutritional Therapy in Pediatric Autologous Transplantation: A Descriptive Cohort Study

Andressa Florencio da Silva1,2, Vera Lucia Bosa2,3, Estela Beatriz Behling1,2

  • 1Nutrition Service. Multiprofessional Health Residency Program: Onco-Hematology, Porto Alegre Clinical Hospital, Porto Alegre, Brazil.

Nutrition and Cancer
|July 19, 2024
PubMed

Insights

Early enteral nutrition is crucial for pediatric hematopoietic stem cell transplant patients. However, nutritional status declined during treatment, highlighting the need for improved enteral nutrition protocols.

Area of Science:

  • Pediatric Hematology
  • Transplant Nutrition
  • Gastroenterology

Background:

  • Pediatric hematopoietic stem cell transplantation (HSCT) necessitates tailored nutritional support.
  • Early enteral nutrition (EN) is recognized for its benefits in pediatric HSCT.
  • This study examines EN practices in autologous HSCT recipients.

Purpose of the Study:

  • To analyze the utilization and impact of enteral nutrition therapy in pediatric patients undergoing autologous HSCT.
  • To assess nutritional and clinical variables during the early post-transplant period.
  • To identify trends in EN formula selection and the need for parenteral nutrition.

Main Methods:

  • Descriptive cohort study utilizing electronic medical records (2017-2022).
  • Inclusion of pediatric patients undergoing autologous HSCT receiving EN.
  • Assessment of nutritional, clinical, and biochemical data at four time points: Day 0, +5, +10, and +15.

Main Results:

  • Fifty patients were included; nasoenteral tubes were typically placed pre-transplant (D-4) with feeding initiated (D-3).
  • Formula type shifted from normocaloric polymeric to hypocaloric semi-elemental by D+10 due to increased diarrhea and mucositis.
  • 35% required parenteral nutrition by D+15, and overall nutritional status worsened from admission to discharge.

Conclusions:

  • Early EN initiation aligns with established practices and literature recommendations.
  • Worsening clinical conditions (diarrhea, mucositis) necessitate formula adjustments and can lead to parenteral nutrition reliance.
  • Development of specific protocols and guidelines for EN in pediatric HSCT is essential for optimizing patient outcomes.

Related Concept Videos

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
103
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
240
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
120
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
321